Julie Hambleton, Director at SpringWorks Therapeutics, Inc. (SWTX), sold 4,836 shares at $29.31 ($142K) on 2023-07-19, disclosed to the SEC on 2023-07-21.
Scheduled sale ($142k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.31 | 2,418 | $71K | 50.0% |
| 2 | $29.31 | 2,418 | $71K | 50.0% |
| Total | $29.31 avg | 4,836 | $142K | 100% |
| Filing → |
| SWTX | SELL | 2024-06-05 | $302K | — | Filing → |
| SWTX | SELL | 2023-06-22 | $129K | — | Filing → |
| SWTX | SELL | 2023-03-16 | $35K | — | Filing → |